Pernod Ricard Sa ADR (PDRDY) 21.8900 $PDRDY Pernod

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pernod Ricard Sa ADR (PDRDY) 21.8900 $PDRDY

Pernod Ricard UK to be Corby's Representative for Lamb's Rum in Great Britain
CNW Group - Tue Mar 22, 4:30AM CDT
Corby Spirit and Wine Limited ("Corby" or the "Company" (TSX: CSW.A, CSW.B) and Pernod Ricard UK Ltd. ("PRUK" announced today that they have entered into an agreement providing PRUK the exclusive right to represent Lamb's® rum in Great Britain as of July 1, 2016, upon termination of the existing third-party representation agreement, for a five year period to June 30, 2021. Pernod Ricard S.A. ("Pernod Ricard" wholly owns PRUK and indirectly owns in excess of 50% of the issued and outstanding Voting Class A Common Shares of Corby and is considered to be both Corby's and PRUK's ultimate parent.

Instant Analysis: Anheuser-Busch InBev SA Makes Big Splash in Hard Soda
Rich Duprey, The Motley Fool - Motley Fool - Tue Dec 15, 1:46PM CST
What happened? Anheuser-Busch InBev launched Best Damn Brewing Co. on Monday in response to the sudden popularity of hard soda. The brewery's first new product, Best Damn Root Beer, is already on store shelves and will offer 5.5% alcohol by...
BUD: 127.75 (+0.56), TAP: 102.56 (+2.71), SAM: 171.13 (+2.60), DEO: 112.80 (-0.84)

Corby Spirit and Wine Announces Extension of Hiram Walker & Sons' Agreements
CNW Group - Mon Sep 28, 3:41PM CDT
Corby Spirit and Wine Limited ("Corby" or the "Company" (TSX: CSW.A, CSW.B) announced today that, for administrative reasons, Corby has entered into an amending agreement with Hiram Walker & Sons Limited ("Hiram Walker" and an affiliate of Pernod Ricard S.A. ("Pernod Ricard" to extend the initial ten-year term of the administrative and production services agreements between the parties to November 30, 2015. All other terms of the original agreements remain the same. Pernod Ricard indirectly owns in excess of 50% of the issued and outstanding Voting Class A Common Shares of Corby and is considered to be Corby's ultimate parent. Since the agreement with Hiram Walker and the affiliate constitute related party transactions, it was approved by the Independent Committee of the Corby Board of Directors following legal review.

Wine Market in Australia - Sparkling Wine Will be the Fastest Growing Category Registering a CAGR of 4.2% During 2014-2019
M2 - Thu Aug 13, 3:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wwjln3/consumer_and) has announced the addition of Canadean Ltd's new report "Consumer and Market Insights: Wine Market in Australia" to their offering. The Consumer and Market Insights: Wine Market in Australia report provides in-depth information on value and volume data by category and distribution channel. Leading brands the most opportunistic foodservice channels and packaging material and container consumption are also covered. Key Findings: - A large proportion of aging population between 30-50 years of age with rising disposable income will create growth opportunities for Wine manufacturers - Of the three Wine categories analyzed Still Wine will remain the largest while Sparkling Wine will be the fastest growing category registering a CAGR of 4.2% during 2014-2019 - The Australian Wine market is highly competitive and is led by domestic players such as Treasury Wine Estates Vintners and Accolade Wines and few international players such as Pernod Ricard S.A. - Hypermarkets and Supermarkets was the leading distribution channel in the Australian Wine market and it accounted for 43.0% of volume distribution of Wine in 2014 What else is contained? - Market data: Overall market value and volume data with growth analysis for 2014-2019 - Category coverage: Value and growth analysis for Still Wine Sparkling Wine and Fortified Wine with inputs on individual segment share within each category and the change in their market share forecast for 2014-2019 - Leading players: Market share of brands and private labels private label growth analysis during 2011-2014 Reasons To Buy: - Identify high potential categories and explore further market opportunities based on detailed value and volume analysis - Existing and new players can analyse key distribution channels to identify and evaluate trends and opportunities Companies Mentioned - McWilliams Harwood Estate Winery - Golden Oak Winery - Treasury Wine Estates Vintners Ltd - Accolade Wines - Brown Brothers Milawa Vineyard Pvt Ltd - Pernod Ricard S.A. - De Bortoli Wines - Hardys Wines - Brancott Estate - Jacob's Creek - Woolworths - Coles - IGA - Aldi. For more information visit http://www.researchandmarkets.com/research/ww...nsumer_and

Will Constellation Brands (STZ) Sustain Momentum in FY16? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 08, 10:50AM CDT
Will Constellation Brands (STZ) sustain its strong performance in the near future?
STZ: 165.99 (-0.02)

Diageo plc (DEO) in Focus: Stock Adds 8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 08, 8:32AM CDT
Diageo plc (DEO) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
DEO: 112.80 (-0.84)

Castle Brands (ROX) Jumps: Stock Rises 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 03, 8:11AM CDT
Castle Brands Inc. (ROX) was a big mover last session, as the company saw its shares rise nearly 10% on the day.
ROX: 0.81 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 175

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 227

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 291

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 87

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 10

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 0

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

NEXE Innovations Unveils Impressive Q3 Financial Performance

Updated Category News Views 289

NEXE Innovations Reports Record Financial Growth WINDSOR, Ontario -- NEXE Innovations Inc. (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a leading player in compostable materials, is excited to share its financial results for the three-month period concluding on February 28, 2025. Showcasing its growth and robust strategies, NEXE has marked significant milestones,...

Continue Reading
Insights into Globus Medical's Upcoming Earnings Report

Updated Category News Views 179

Anticipation for Globus Medical's Earnings Report Globus Medical (NYSE: GMED) is preparing to unveil its quarterly earnings report soon. Investors are eager to discover the outcomes that could influence their investment decisions, and this report is no exception. With increasing excitement surrounding the earnings announcement, analysts project earnings per share (EPS) to...

Continue Reading
Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 278

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Royce Micro-Cap Trust Announces Q4 Distribution Details

Updated Category News Views 176

Royce Micro-Cap Trust Announces Fourth Quarter Distribution Royce Micro-Cap Trust, Inc. (NYSE-RMT) has proudly declared a significant fourth quarter distribution, amounting to $0.24 per share on its Common Stock. This distribution not only underscores the Trust's commitment to its shareholders but also allows them the option to receive the payout in cash or as additional...

Continue Reading
Cellectis Showcases Innovations in Non-Viral Gene Therapy at Congress

Updated Category News Views 214

Exciting Advances in Gene Therapy by Cellectis Cellectis, a clinical-stage biotechnology company, is making headlines with its innovative approach to gene therapy, particularly in the exciting world of gene editing. Recently, the company announced significant findings regarding the potential of circular single-stranded DNA (CssDNA) as a universal non-viral template for...

Continue Reading